Influence of Bariatric Surgery on the Use and Pharmacokinetics of Some Major Drug Classes |
| |
Authors: | Jan Peter Yska Susanne van der Linde Véronique V. Tapper Jan A. Apers Marloes Emous Erik R. Totté Bob Wilffert Eric N. van Roon |
| |
Affiliation: | 1. Department of Clinical Pharmacy and Clinical Pharmacology, Medisch Centrum Leeuwarden, PO Box 888, 8901 BR, Leeuwarden, The Netherlands 2. Department of Surgery, Medisch Centrum Leeuwarden, Leeuwarden, The Netherlands 3. Unit of Pharmacotherapy and Pharmaceutical Care, Department of Pharmacy, University of Groningen, Groningen, The Netherlands 4. Department of Hospital and Clinical Pharmacy, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
|
| |
Abstract: | The purpose of this review is to evaluate the influence of bariatric surgery on the use and pharmacokinetics of some frequently used drugs. A PubMed literature search was conducted. Literature was included on influence of bariatric surgery on pharmacoepidemiology and pharmacokinetics. Drug classes to be searched for were antidepressants, antidiabetics, statins, antihypertensive agents, corticosteroids, oral contraceptives, and thyroid drugs. A reduction in the use of medication by patients after bariatric surgery has been reported for various drug classes. Very few studies have been published on the influence of bariatric surgery on the pharmacokinetics of drugs. After bariatric surgery, theoretically, reduced drug absorption may occur. Correct dosing and choosing the right dosage form for drugs used by patients after bariatric surgery are necessary for optimal pharmacotherapy. Therefore, more clinical studies are needed on the influence of bariatric surgery on the pharmacokinetics of major drugs. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|